Medtronic develops first left-side pacemaker:
This article was originally published in Clinica
Executive Summary
Medtronic (Japan) has produced a left-side dual-chamber pacemaker for its Thera "i-series" pacemaker family. The company claims that its product is the first that can be implanted on either side of the heart. Previously, cardiologists implanting pacemakers on the left side of the heart have turned the pacemaker over, but this has complicated lead-wrapping. The size of the pacemaker has also been reduced to fit the smaller Japanese body. The product is available in Japan for ¥.97 million ($18,410).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.